July 9, 2012 — Endosystems Inc., a medical device company developing technology for endovascular aneurysm repair (EVAR) ...
Diagnostic and Interventional Cardiology DAIC
Diagnostic and Interventional Cardiology (DAIC) is a magazine that reaches more than 25,000 healthcare professionals in cardiology, interventional cardiology and cath labs across the United States. These influential buying team members rely on DAIC's award-winning editorial content and comparison charts as a unique research tool for specifying, recommending and approving technology/device purchases.
July 6, 2012 — Boston Scientific Corp. has completed enrollment in the PREVAIL confirmatory study, designed to gain U.S ...
Three big trends were seen in cardiovascular ultrasound during the American Society of Echocardiography (ASE) 2012 ...
July 3, 2012 — Researchers have announced the results of a study that highlights the importance of performing an ...
June 28, 2012 — In upholding the Affordable Care Act (ACA), the U.S. Supreme Court sent a clear message that patients ...
June 22, 2012 — The University of Miami Miller School of Medicine’s Interdisciplinary Stem Cell Institute (ISCI) ...
June 22, 2012 –– The U.S. Food and Drug Administration (FDA) recently selected a stent graft being developed by ...
June 21, 2012 — Surefire Medical Inc. announced that it has received 510(k) U.S. Food and Drug Administration (FDA) ...
June 20, 2012 — Echocardiography is playing a key role in both the assessment and guidance of transcatheter aortic valve ...
June 18, 2012 — St. Jude Medical Inc. announced it has received U.S. Food and Drug Administration (FDA) clearance and ...
June 15, 2012 — Cardiosolutions Inc. announced it has received 510(k) clearance from the U.S. Food and Drug ...
June 15, 2012 — CardiAQ Valve Technologies (CardiAQ), which has developed the world’s first self-conforming and self ...
June 14, 2012 — A U.S. Food and Drug Administration (FDA) advisory panel voted in favor of recommending expanding the ...
June 14, 2012 — Abiomed Inc. said today it received Health Canada approval to market the Impella cVAD (ventricular ...
June 11, 2012 — Critical Diagnostics, a U.S.-based biomarker company focused on cardiovascular diseases, and Health ...
July 09, 2012